Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Management of the Endometrioma on Ovarian Reserve
Sponsor: University of Valencia
Summary
Investigators aimed at comparing the impact on ovarian reserve of three usual-care management options of endometrioma, laparoscopic cystectomy (LC), hormonal treatment with daily dienogest (HT), or mere ultrasound control (UC). Ovarian reserve will be measured by the effect on the circulating levels of anti-Mullerian hormone (AMH). Secondary objectives will be effect on pelvic pain, other symptoms, sexual function, quality of life, progression in size of the endometrioma, impact on work productivity and activity impairment, and satisfaction with treatment. Participants will be followed by up to one year.
Official title: Impact of the Type of Treatment of the Endometrioma on Ovarian Reserve
Key Details
Gender
FEMALE
Age Range
18 Years - 39 Years
Study Type
OBSERVATIONAL
Enrollment
0
Start Date
2023-03-14
Completion Date
2026-11-02
Last Updated
2026-07-08
Healthy Volunteers
No
Conditions
Interventions
Dienogest
Some women in the cohort will be treated with dienogest for one year after consensus with the physician
Laparoscopic cystectomy
Some women in the cohort will be treated with laparoscopic cystectomy after consensus with the physician
Control with ultrasound without other type of intervention
Some women in the cohort will be followed with ultrasound control, without other intervention, after consensus with the physician
Locations (2)
University Hospital Poznan
Poznan, Poznan, Poland
Hosp Clinico Universitario-INCLIVA
Valencia, Valencia, Spain